DÄ internationalArchive4/2007Paroxysmal Nocturnal Hemoglobinuria

Review article

Paroxysmal Nocturnal Hemoglobinuria

Dtsch Arztebl 2007; 104(4): A-192

Röth, A; Dührsen, U

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Parker C, Omine M, Richards S et al.: Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005; 106: 3699–709. MEDLINE
2. Dacie JV, Lewis SM: Paroxysmal nocturnal haemoglobinuria: clinical manifestations, haematology, and nature of the disease. Ser Haematol 1972; 5: 3–23. MEDLINE
3. Luzzatto L, Bessler M: The dual pathogenesis of paroxysmal nocturnal hemoglobinuria. Curr Opin Hematol 1996; 3: 101–10. MEDLINE
4. Rosse WF: Paroxysmal nocturnal hemoglobinuria as a molecular disease. Medicine (Baltimore) 1997; 76: 63- 93.
5. Hillmen P, Richards SJ: Implications of recent insights into the pathophysiology of paroxysmal nocturnal haemoglobinuria. Br J Haematol 2000; 108: 470–9. MEDLINE
6. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV: Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995; 333: 1253–8. MEDLINE
7. Socie G, Mary JY, de Gramont A et al.: Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet 1996; 348: 573–7. MEDLINE
8. Wiedmer T, Hall SE, Ortel TL, Kane WH, Rosse WF, Sims PJ: Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 1993; 82: 1192–6. MEDLINE
9. Hugel B, Socie G, Vu T et al.: Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 1999; 93: 3451–6. MEDLINE
10. Socie G, Rosenfeld S, Frickhofen N, Gluckman E, Tichelli A: Late clonal diseases of treated aplastic anemia. Semin Hematol 2000; 37: 91–101. MEDLINE
11. Rosse WF, Hillmen P, Schreiber AD: Immune-mediated hemolytic anemia. Hematology (Am Soc Hematol Educ Program) 2004: 48–62. MEDLINE
12. Rother RP, Bell L, Hillmen P, Gladwin MT: The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293: 1653–62. MEDLINE
13. Schubert J, Alvarado M, Uciechowski P et al.: Diagnosis of paroxysmal nocturnal haemoglobinuria using immunophenotyping of peripheral blood cells. Br J Haematol 1991; 79: 487–92. MEDLINE
14. Hall SE, Rosse WF: The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 1996; 87: 5332–40. MEDLINE
15. Brodsky RA, Mukhina GL, Li S et al.: Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol 2000; 114: 459–66. MEDLINE
16. Brecher ME, Taswell HF: Paroxysmal nocturnal hemoglobinuria and the transfusion of washed red cells. A myth revisited. Transfusion 1989; 29: 681–5. MEDLINE
17. Issaragrisil S, Piankijagum A, Tangnaitrisorana Y: Corticosteroids therapy in paroxysmal nocturnal hemoglobinuria. Am J Hematol 1987; 25: 77–83. MEDLINE
18. Bourantas K: High-dose recombinant human erythropoietin and low-dose corticosteroids for treatment of anemia in paroxysmal nocturnal hemoglobinuria. Acta Haematol 1994; 91: 62–5. MEDLINE
19. Zhao M, Shao Z, Li K et al.: Clinical analysis of 78 cases of paroxysmal nocturnal hemoglobinuria diagnosed in the past ten years. Chin Med J (Engl) 2002; 115: 398–401. MEDLINE
20. Hall C, Richards S, Hillmen P: Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood 2003; 102: 3587–91. MEDLINE
21. Saso R, Marsh J, Cevreska L et al.: Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. Br J Haematol 1999; 104: 392–6. MEDLINE
22. Hegenbart U, Niederwieser D, Forman S et al.: Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant 2003; 9: 689–97. MEDLINE
23. Hill A, Rother RP, Hillmen P: Improvement in the symptoms of smooth muscle dystonia during eculizumab therapy in paroxysmal nocturnal hemoglobinuria. Haematologica 2005; 90 (12 Suppl): ECR40. MEDLINE
24. Hillmen P, Hall C, Marsh JC et al.: Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 2004; 350: 552–9. MEDLINE
25. Hill A, Hillmen P, Richards SJ et al.: Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria. Blood 2005; 106: 2559–65. MEDLINE